Get the Stockscreener App
2.54
2.31%
-0.06
Kiora Pharmaceuticals Inc stock is traded at $2.54, with a volume of 63,059.
It is down -2.31% in the last 24 hours and down -9.93% over the past month.
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.
See More
Previous Close:
$2.60
Open:
$2.62
24h Volume:
63,059
Relative Volume:
0.15
Market Cap:
$7.73M
Revenue:
-
Net Income/Loss:
$2.81M
P/E Ratio:
-0.177
EPS:
-14.3497
Net Cash Flow:
$7.14M
1W Performance:
-15.05%
1M Performance:
-9.93%
6M Performance:
-36.97%
1Y Performance:
-43.93%
1-Day Range:
$2.51
$2.63
1-Week Range:
$2.51
$3.0599
52-Week Range:
$2.51
$4.77
Kiora Pharmaceuticals Inc Stock (KPRX) Company Profile
Name
Kiora Pharmaceuticals Inc
Sector
Industry
Phone
781-788-8869
Address
332 ENCINITAS BOULEVARD, ENCINITAS
Compare KPRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KPRX
Kiora Pharmaceuticals Inc
|
2.54 | 7.91M | 0 | 2.81M | 7.14M | -14.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Kiora Pharmaceuticals Inc Stock (KPRX) Latest News
Can Kiora Pharmaceuticals Inc. stock recover from recent declineWeekly Chart Watchlist with Trade Guidance - Newser
Kiora Pharmaceuticals (KPRX) to Release Earnings on Friday - Defense World
Applying chart zones and confluence areas to Kiora Pharmaceuticals Inc.Short Term Momentum Based Trading Strategy - Newser
How strong is Kiora Pharmaceuticals Inc. company’s balance sheetFree Stock Target Finder With Proven Results - jammulinksnews.com
Kiora Pharmaceuticals Inc.’s Beta Climbs After Market VolatilityFast Gaining Stock Screener Reports Released - metal.it
Vicarious Surgical appoints Stephen From as new CEO By Investing.com - Investing.com India
Applying big data sentiment scoring on Kiora Pharmaceuticals Inc.Yearly Trend Summary and Opportunity Breakdown - Newser
Strategies to average down on Kiora Pharmaceuticals Inc.Free Stock Market Watch With Alerts - Newser
Applying sector rotation models to Kiora Pharmaceuticals Inc.Buy Candidate Summary Based on Fundamentals - Newser
Sentiment analysis tools applied to Kiora Pharmaceuticals Inc.Value Investing Checklist with Entry Signals - Newser
Kiora Pharmaceuticals Inc. stock chart pattern explainedLow Risk High Confidence Watchlist Builder - Newser
Visualizing Kiora Pharmaceuticals Inc. stock with heatmapsFree Community Shared Smart Money Signals - Newser
Published on: 2025-07-31 22:25:14 - Newser
How to interpret RSI for Kiora Pharmaceuticals Inc. stockStock Entry Points Based on Technicals - Newser
Why is Kiora Pharmaceuticals Inc. stock attracting strong analyst attentionWealth Building Guidance For Smart Trading - jammulinksnews.com
What makes Kiora Pharmaceuticals Inc. stock price move sharplySwing Trade Entry Points For Fast Growth - jammulinksnews.com
Kiora Pharmaceuticals Inc. Stock Support and Resistance Levels You Should KnowWeekly High Conviction Trade Setup Analysis - Newser
Why Kiora Pharmaceuticals Inc. stock attracts strong analyst attentionWeekly Portfolio Update with ROI Focus - Newser
What earnings revisions data tells us about Kiora Pharmaceuticals Inc.Free Swing Trade With Risk Management - Newser
What data driven models say about Kiora Pharmaceuticals Inc.’s futureTrend Reversal Probability Forecast Update - Newser
Multi Factor Analysis Ranks Kiora Pharmaceuticals Inc. as Strong BuyQuick Gain Stock Watch With Indicators Reviewed - metal.it
Kiora Pharmaceuticals Inc. stock trend outlook and recovery pathVolume Based Swing Signal Prediction Map - Newser
Kiora Pharmaceuticals Inc. Company Revenue and Profit Trends: A Deep DiveWeekly Watchlist of High Movers Released - metal.it
Published on: 2025-07-29 07:37:38 - metal.it
What are analysts’ price targets for Kiora Pharmaceuticals Inc. in the next 12 monthsNavigate market shifts with confidence - jammulinksnews.com
What are the latest earnings results for Kiora Pharmaceuticals Inc.Phenomenal trading returns - jammulinksnews.com
What is the risk reward ratio of investing in Kiora Pharmaceuticals Inc. stockMaximize portfolio value with smart investment plans - jammulinksnews.com
What is Kiora Pharmaceuticals Inc. company’s growth strategyStay informed with expert market forecasts - jammulinksnews.com
What catalysts could drive Kiora Pharmaceuticals Inc. stock higher in 2025Remarkably fast returns - jammulinksnews.com
Kiora Pharmaceuticals Inc Stock (KPRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):